Skip to main content
Log in

Clinical trial of attenuated vaccinia virus AS strain in the treatment of advanced adenocarcinoma

Report on two cases

  • Short Communication
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Summary

Two cases of advanced adenocarcinoma treated with attenuated vaccinia virus AS strain are reported. One was a primary lung adenocarcinoma with metastatic lesions in brain, right kidney, and rib. The other was a left renal adenocarinoma with multiple lung and vertebral metastases. In both patients, good antitumor effects against lung and bone lesions were obtained, respectively, and no adverse reactions were noted. Therefore, treatemtn of patients with AS vaccinia virus appears to suppress the growth of tumor cells without adverse effects on normal human cells. This is the first report to describe the effects of attenuated vaccinia virus AS strain on human cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Arakawa S, Fukai K (1983) The effect of attenuated vaccinia virus AS strain on N-methyl-N′-nitro-N-Nitrosoguanidine-induced gastric cancer in rats. J Cancer Res Clin Oncol 105:117–126

    PubMed  Google Scholar 

  • Bassil B, Dosoretz DE, Prout GR Jr (1985) Validation of the tumor, nodes and metastasis classification of renal cell carcinoma. J Urol 134:450–454

    PubMed  Google Scholar 

  • Epstein MA (1985) An investigation into the purifying effect of a fluorocarbon on vaccinia virus. Br J Exp Pathol 39:436–445

    Google Scholar 

  • Fujiwara H, Shimizu Y, Takai Y, Wakamiya N, Ueda S, Kato S, Hamaoka T (1984) The augmentation of tumor-specific immunity by virus help I. Demonstration of vaccinia virus-reactive helper T cell activity involved in enhanced induction of cytotoxic T lymphocyte and antibody responses. Eur J Immunol 14:171–175

    PubMed  Google Scholar 

  • Fukai K, Monoe T, Yamamoto H, Arakawa S, Niimi I, Tokuda M (1981) Morphological studies on antitumor activity of attenuated vaccinia virus AS strain upon transplantable mouse tumor. Proceedings of the Japanese Cancer Association of the 40th Annual Meeting, p 89

  • Shimizu Y, Fujiwara H, Ueda S, Wakamiya N, Kato S, Hamaoka T (1984) The augmentation of tumor-specific immunity by virus help. II. Enhanced induction of cytotoxic T lymphocyte and antibody responses to tumor antigens by vaccinia virus reactive helper T cells. Eur J Immunol 14:839–843

    PubMed  Google Scholar 

  • Skinner DG, Colvin RB, Vermillion CD, Phister RC, Leadbetter WF (1971) Diagnosis and management of renal cell carcinoma —A clinical and pathologic study of 309 cases. Cancer 28:1165–1177

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arakawa, S., Hamami, G., Umezu, K. et al. Clinical trial of attenuated vaccinia virus AS strain in the treatment of advanced adenocarcinoma. J Cancer Res Clin Oncol 113, 95–98 (1987). https://doi.org/10.1007/BF00389974

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00389974

Key words

Navigation